MAR 19, 2014 01:00 PM PDT

ABCA1 and APOE: Intertwined roles in Alzheimers disease

Presented At Neuroscience
Speakers
  • Associate Professor at the Department of Environmental & Occupational Health, University of Pittsburgh
    Biography
      Radosveta (Rada) Koldamova, MD, PhD is Associate Professor at the Department of Environmental & Occupational Health, University of Pittsburgh, Pittsburgh, PA. Dr. Koldamova research has been distinguished by groundbreaking findings in the area of Nuclear Receptor biology in brain and their targets, relevant to AD pathogenesis and therapy. Prior to her appointment at Pitt in 1995, Dr. Koldamova served as a General Practitioner and an Instructor and Lecturer in Biochemistry at the School of Medicine, Stara Zagora, Bulgaria. She defended her PhD thesis in Biochemistry and Molecular Biology at the Bulgarian Academy of Sciences. From 1995 to 2005, she was a postdoctoral fellow and then Assistant Professor at the Department of Pharmacology, School of Medicine University of Pittsburgh. While at Pharmacology, Dr. Koldamova discovered the role of cholesterol transporter ABCA1 and its transcriptional regulators LXR/RXR in AD using in vitro and in vivo model systems. The original reports published by Dr. Koldamova on biology of brain LXR, ABCA1 and therapeutic approaches for AD based on ligand activated NR established a new and fruitful area of AD research. Dr. Koldamova has served on numerous academic, scientific, and professional committees. She is a member of the Society for Neuroscience, International Society to Advance Alzheimer Research and Treatment, and American Society for Biochemistry and Molecular Biology, and is a Principal Investigator on Federal Agencies and Private foundations funded grant awards.

    Abstract:

    ATP-binding cassette transporter A1 (ABCA1) mediates cholesterol efflux to lipid-free apolipoproteins such as apolipoprotein A-I (apoA-I) and apolipoprotein E (apoE). ABCA1 is essential regulator of high density lipoprotein generation (HDL) a role that defines its significance for cardiovascular disease. ABCA1 and APOE are transcriptionally regulated by Liver X Receptors (LXR) and Retinoic X Receptors (RXR).
    The inheritance of 4 allele of APOE is the major genetic risk factor for late-onset Alzheimers disease (AD). Patients carrying APOE4 allele, compared to those with the other two isoforms, have more amyloid plaques a finding replicated in human Amyloid precursor protein (APP) transgenic mice. Recent data suggest that ABCA1 via its control over apoE lipidation may have a role in AD. Studies from our and other groups have demonstrated that lack of ABCA1 increases amyloid deposition and cognitive decline in different AD model mice accompanied by significant decrease in the levels of apoE and apoA-I. In contrast, treatment with LXR or RXR ligands increases ABCA1 and apoE levels and significantly ameliorates amyloid pathology. In a recent study using APP mice we demonstrated that ABCA1 haplo deficiency had a differential effect on the phenotype of APOE3 or APOE4 expressing mice. The lack of one copy of Abca1 significantly aggravated memory deficits, Aβ plaques and Aβ clearance in APP/APOE4 but not in APP/APOE3 mice. Interestingly, we found a correlation between HDL in plasma and amyloid load in brain, suggesting a causative connection between peripheral lipoproteins and Aβ load in the CNS.
    In conclusion, these studies demonstrate that future therapies targeting ABCA1 and APOE expression such as LXR/RXR agonists could have a favorable effect on the outcome in AD patients including APO4 carriers.
     


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    Loading Comments...
    Show Resources